PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
-3.96%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.3B
AUM Growth
-$438M
(-16%)
Cap. Flow
-$251M
Cap. Flow
% of AUM
-10.88%
Top 10 Holdings %
Top 10 Hldgs %
35.75%
Holding
1,125
New
22
Increased
279
Reduced
683
Closed
141
Top Buys
| 1 |
DoorDash
DASH
|
+$1.58M |
| 2 |
Arista Networks
ANET
|
+$1.41M |
| 3 |
TSMC
TSM
|
+$1.39M |
| 4 |
Salesforce
CRM
|
+$1.34M |
| 5 |
JD.com
JD
|
+$1.26M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$34.4M |
| 2 |
Apple
AAPL
|
+$16.5M |
| 3 |
Microsoft
MSFT
|
+$13.2M |
| 4 |
Broadcom
AVGO
|
+$12.7M |
| 5 |
Amazon
AMZN
|
+$7.27M |
Sector Composition
| 1 | Technology | 41.42% |
| 2 | Consumer Discretionary | 11.82% |
| 3 | Communication Services | 10.93% |
| 4 | Healthcare | 10.6% |
| 5 | Financials | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Capricor Therapeutics
CAPR
$288M
| $162K | 0.01% |
17,108
-6,899
| -29% | -$65.5K |
|
927
Amneal Pharmaceuticals
AMRX
$3.04B
| $161K | 0.01% |
19,271
-1,825
| -9% | -$15.3K |
|
928
Fortuna Silver Mines
FSM
$2.36B
| $161K | 0.01% |
26,418
+5,500
| +26% | +$33.6K |
|
929
Sandstorm Gold
SAND
$3.37B
| $160K | 0.01% |
21,204
+4,755
| +29% | +$35.9K |
|
930
BGC Group
BGC
$4.73B
| $154K | 0.01% |
16,764
-3,661
| -18% | -$33.6K |
|
931
ProPetro Holding
PUMP
$481M
| $151K | 0.01% |
20,578
+3,885
| +23% | +$28.6K |
|
932
Altimmune
ALT
$328M
| $149K | 0.01% |
29,759
-791
| -3% | -$3.96K |
|
933
Immunome
IMNM
$774M
| $145K | 0.01% |
21,601
+5,507
| +34% | +$37.1K |
|
934
Genworth Financial
GNW
$3.5B
| $133K | 0.01% |
18,799
-6,350
| -25% | -$45K |
|
935
Apple Hospitality REIT
APLE
$3B
| $132K | 0.01% |
10,253
-2,320
| -18% | -$30K |
|
|
WBA
936
DELISTED
Walgreens Boots Alliance
WBA
| $132K | 0.01% |
+11,835
| New | +$132K |
|
937
Aurora
AUR
$10.5B
| $120K | 0.01% |
17,827
-3,781
| -17% | -$25.4K |
|
938
Keros Therapeutics
KROS
$634M
| $118K | 0.01% |
+11,569
| New | +$118K |
|
939
Ocular Therapeutix
OCUL
$2.24B
| $117K | 0.01% |
15,913
-4,608
| -22% | -$33.8K |
|
940
MiMedx Group
MDXG
$1.05B
| $115K | 0.01% |
15,179
+3,287
| +28% | +$25K |
|
|
CGAU
941
Centerra Gold
CGAU
$1.8B
| $115K | 0.01% |
+18,117
| New | +$115K |
|
942
Relay Therapeutics
RLAY
$703M
| $112K | ﹤0.01% |
42,929
-5,610
| -12% | -$14.7K |
|
943
Viavi Solutions
VIAV
$2.59B
| $112K | ﹤0.01% |
10,045
-2,387
| -19% | -$26.7K |
|
944
LXP Industrial Trust
LXP
$2.68B
| $112K | ﹤0.01% |
12,967
-4,228
| -25% | -$36.6K |
|
945
Xeris Biopharma Holdings
XERS
$1.24B
| $111K | ﹤0.01% |
20,192
-2,777
| -12% | -$15.2K |
|
946
Arcturus Therapeutics
ARCT
$496M
| $108K | ﹤0.01% |
10,221
-865
| -8% | -$9.16K |
|
|
VERV
947
DELISTED
Verve Therapeutics
VERV
| $108K | ﹤0.01% |
23,606
-3,028
| -11% | -$13.8K |
|
948
Emergent Biosolutions
EBS
$441M
| $107K | ﹤0.01% |
21,992
-4,569
| -17% | -$22.2K |
|
949
Goodyear
GT
$2.43B
| $106K | ﹤0.01% |
11,456
-1,474
| -11% | -$13.6K |
|
950
RPC Inc
RES
$1.03B
| $105K | ﹤0.01% |
19,072
-1,920
| -9% | -$10.6K |
|